Literature DB >> 15781294

Free radical production induced by methamphetamine in rat striatal synaptosomes.

David Pubill1, Carlos Chipana, Antonio Camins, Mercè Pallàs, Jordi Camarasa, Elena Escubedo.   

Abstract

The pro-oxidative effect of methamphetamine (METH) in dopamine terminals was studied in rat striatal synaptosomes. Flow cytometry analysis showed increased production of reactive oxygen species (ROS) in METH-treated synaptosomes, without reduction in the density of dopamine transporters. In synaptosomes from dopamine (DA)-depleted animals, METH did not induce ROS production. Reserpine, in vitro, completely inhibited METH-induced ROS production. These results point to endogenous DA as the main source of ROS induced by METH. Antioxidants and inhibitors of neuronal nitric oxide synthase and protein kinase C (PKC) prevented the METH-induced oxidative effect. EGTA and the specific antagonist methyllycaconitine (MLA, 50 microM) prevented METH-induced ROS production, thus implicating calcium and alpha7 nicotinic receptors in such effect. Higher concentrations of MLA (>100 microM) showed nonspecific antioxidant effect. Preincubation of synaptosomes with METH (1 microM) for 30 min reduced [(3)H]DA uptake by 0%. The METH effect was attenuated by MLA and EGTA and potentiated by nicotine, indicating that activation of alpha(7) nicotinic receptors and Ca(2+) entry are necessary and take place before DAT inhibition. From these findings, it can be postulated that, in our model, METH induces DA release from synaptic vesicles to the cytosol. Simultaneously, METH activates alpha(7) nicotinic receptors, probably inducing depolarization and an increase in intrasynaptosomal Ca(2+). This would lead to DAT inhibition and NOS and PKC activation, initiating oxidation of cytosolic DA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15781294     DOI: 10.1016/j.taap.2004.08.008

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  27 in total

1.  Nrf2 gene deletion fails to alter psychostimulant-induced behavior or neurotoxicity.

Authors:  Alejandra M Pacchioni; Joseph Vallone; Roberto I Melendez; Andy Shih; Timothy H Murphy; Peter W Kalivas
Journal:  Brain Res       Date:  2006-11-17       Impact factor: 3.252

Review 2.  Altered energy production, lowered antioxidant potential, and inflammatory processes mediate CNS damage associated with abuse of the psychostimulants MDMA and methamphetamine.

Authors:  Luke A Downey; Jennifer M Loftis
Journal:  Eur J Pharmacol       Date:  2014-01-28       Impact factor: 4.432

3.  In vivo evidence of methamphetamine induced attenuation of brain tissue oxygenation as measured by EPR oximetry.

Authors:  John Weaver; Yirong Yang; Rebecca Purvis; Theodore Weatherwax; Gerald M Rosen; Ke Jian Liu
Journal:  Toxicol Appl Pharmacol       Date:  2014-01-08       Impact factor: 4.219

Review 4.  Neurotoxins and neurotoxicity mechanisms. An overview.

Authors:  Juan Segura-Aguilar; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2006-12       Impact factor: 3.911

5.  Comparative neuropharmacology of three psychostimulant cathinone derivatives: butylone, mephedrone and methylone.

Authors:  Raul López-Arnau; Jose Martínez-Clemente; David Pubill; Elena Escubedo; Jorge Camarasa
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

6.  Neurotoxic effects of methamphetamine on rat hippocampus pyramidal neurons.

Authors:  N Hori; M T Kadota; M Watanabe; Y Ito; N Akaike; D O Carpenter
Journal:  Cell Mol Neurobiol       Date:  2010-03-16       Impact factor: 5.046

7.  Methamphetamine-induced locomotor changes are dependent on age, dose and genotype.

Authors:  Renee L Good; Richard A Radcliffe
Journal:  Pharmacol Biochem Behav       Date:  2010-12-14       Impact factor: 3.533

Review 8.  Does restraining nitric oxide biosynthesis rescue from toxins-induced parkinsonism and sporadic Parkinson's disease?

Authors:  Satya Prakash Gupta; Sharawan Yadav; Naveen Kumar Singhal; Manindra Nath Tiwari; Sarad Kumar Mishra; Mahendra Pratap Singh
Journal:  Mol Neurobiol       Date:  2013-07-31       Impact factor: 5.590

9.  Neurotoxic effects of methamphetamine.

Authors:  Bessy Thrash; Senthilkumar S Karuppagounder; Subramaniam Uthayathas; Vishnu Suppiramaniam; Muralikrishnan Dhanasekaran
Journal:  Neurochem Res       Date:  2009-08-21       Impact factor: 3.996

Review 10.  Neuroimmune basis of methamphetamine toxicity.

Authors:  Jennifer M Loftis; Aaron Janowsky
Journal:  Int Rev Neurobiol       Date:  2014       Impact factor: 3.230

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.